COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study / Galit EREZ ; Orly WEINSTEIN ; Arnon Dov COHEN ; Dana TZUR BITAN in Journal of Autism and Developmental Disorders, 53-2 (February 2023)  

Public ISBD [article]  inJournal of Autism and Developmental Disorders > 53-2 (February 2023) . - p.789-794 Titre : COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study Type de document : Texte imprimé et/ou numérique Auteurs : Galit EREZ, Auteur ; Orly WEINSTEIN, Auteur ; Arnon Dov COHEN, Auteur ; Dana TZUR BITAN, Auteur Article en page(s) : p.789-794 Langues : Anglais (eng) Index. décimale : PER Périodiques Résumé : In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40-60 (OR = 2.05, 95%CI 1.33-3.15, p < .001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14-5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks. En ligne : https://doi.org/10.1007/s10803-021-05187-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=495 [article] COVID-19 Morbidity Among Individuals with Autistic Spectrum Disorder: A Matched Controlled Population-Based Study [Texte imprimé et/ou numérique] / Galit EREZ, Auteur ; Orly WEINSTEIN, Auteur ; Arnon Dov COHEN, Auteur ; Dana TZUR BITAN, Auteur . - p.789-794. Langues : Anglais (eng) in Journal of Autism and Developmental Disorders > 53-2 (February 2023) . - p.789-794 Index. décimale : PER Périodiques Résumé : In this study we aimed to assess whether individuals with ASD are prone to higher infection rates, or to severe COVID-19 illness. Individuals with ASD and age- and gender-matched controlled counterparts (total n = 32,812) were assessed for COVID-19 infection rates and hospitalizations. Results indicated higher infection rates among individuals with ASD, with the largest effect among individuals aged 40-60 (OR = 2.05, 95%CI 1.33-3.15, p < .001), as well as higher odds for hospitalizations, evident primarily in men (OR = 2.40, 95%CI 1.14-5.02, p = 0.02) but not women. Medical and environmental risk factors may associate ASD with higher infection and morbidity rates. Healthcare policy providers should consider proactive steps to protect this population from the associated risks. En ligne : https://doi.org/10.1007/s10803-021-05187-2 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=495

COVID-19 vaccination among individuals with autism spectrum disorder: A population-based study / Orly WEINSTEIN in Research in Autism Spectrum Disorders, 89 (November 2021)  

Public ISBD [article]  inResearch in Autism Spectrum Disorders > 89 (November 2021) . - 101865 Titre : COVID-19 vaccination among individuals with autism spectrum disorder: A population-based study Type de document : Texte imprimé et/ou numérique Auteurs : Orly WEINSTEIN, Auteur ; Israel KRIEGER, Auteur ; Arnon Dov COHEN, Auteur ; Dana TZUR BITAN, Auteur Article en page(s) : 101865 Langues : Anglais (eng) Mots-clés : Autism spectrum disorder  COVID-19  Vaccination  Cohort Index. décimale : PER Périodiques Résumé : Background Individuals with autistic spectrum disorder (ASD) are more susceptible to COVID-19 morbidity and should therefore be prioritized for vaccination. Although individuals with neurodevelopmental disabilities are given some priority in Israel, it is unclear to what extent individuals with ASD are being vaccinated relative to that of the general population. This study was aimed to assess vaccination prevalence among individuals with ASD. Method Individuals with ASD, and age- and sex-matched controls (total n = 11,080), were assessed for prevalence of COVID-19 vaccination by February 2021, approximately a month and a half after the national vaccination distribution plan was launched in Israel. Data were obtained from the database of Clalit Health Services (CHS), the largest healthcare organization in Israel. Results Individuals with ASD were more likely to be vaccinated for COVID-19 (OR = 2.55, 95 %CI 2.35–2.75, p < .001) across both sexes, but only in the 16–20 (OR = 2.04, 95 %CI 1.79–2.32, p < .001) and 21?40 (OR = 3.95, 95 %CI 3.52–4.43, p < .001) age groups. After adjusting for chronic illnesses, ASD remained significant in predicting the uptake of COVID-19 vaccination. Conclusions Efforts to prioritize ASD patients may improve vaccination prevalence among individuals with ASD, especially among younger individuals. Healthcare providers worldwide should therefore consider prioritization policies so as to increase vaccination rates among this vulnerable population. En ligne : https://doi.org/10.1016/j.rasd.2021.101865 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=458 [article] COVID-19 vaccination among individuals with autism spectrum disorder: A population-based study [Texte imprimé et/ou numérique] / Orly WEINSTEIN, Auteur ; Israel KRIEGER, Auteur ; Arnon Dov COHEN, Auteur ; Dana TZUR BITAN, Auteur . - 101865. Langues : Anglais (eng) in Research in Autism Spectrum Disorders > 89 (November 2021) . - 101865 Mots-clés : Autism spectrum disorder  COVID-19  Vaccination  Cohort Index. décimale : PER Périodiques Résumé : Background Individuals with autistic spectrum disorder (ASD) are more susceptible to COVID-19 morbidity and should therefore be prioritized for vaccination. Although individuals with neurodevelopmental disabilities are given some priority in Israel, it is unclear to what extent individuals with ASD are being vaccinated relative to that of the general population. This study was aimed to assess vaccination prevalence among individuals with ASD. Method Individuals with ASD, and age- and sex-matched controls (total n = 11,080), were assessed for prevalence of COVID-19 vaccination by February 2021, approximately a month and a half after the national vaccination distribution plan was launched in Israel. Data were obtained from the database of Clalit Health Services (CHS), the largest healthcare organization in Israel. Results Individuals with ASD were more likely to be vaccinated for COVID-19 (OR = 2.55, 95 %CI 2.35–2.75, p < .001) across both sexes, but only in the 16–20 (OR = 2.04, 95 %CI 1.79–2.32, p < .001) and 21?40 (OR = 3.95, 95 %CI 3.52–4.43, p < .001) age groups. After adjusting for chronic illnesses, ASD remained significant in predicting the uptake of COVID-19 vaccination. Conclusions Efforts to prioritize ASD patients may improve vaccination prevalence among individuals with ASD, especially among younger individuals. Healthcare providers worldwide should therefore consider prioritization policies so as to increase vaccination rates among this vulnerable population. En ligne : https://doi.org/10.1016/j.rasd.2021.101865 Permalink : https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=458

---

1 (1 - 2 / 2)